SCHEMBL23705204

SCHEMBL23705204

OCC1OC2C(C(O)C1O)C2(Cl)Cl

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LGALS1 P09382 2/20 0.41
LGALS3 P17931 2/20 0.41
LGALS9 O00182 1/20 0.41
LGALS8 O00214 1/20 0.41
PYGB P11216 1/20 0.36
OGA O60502 8/20 0.35
HEXB P07686 2/20 0.35
HEXA P06865 1/20 0.35
CA12 O43570 3/20 0.33
CA1 P00915 3/20 0.33
CA2 P00918 3/20 0.33
CA9 Q16790 3/20 0.33
ALDH1A1 P00352 2/20 0.33
TSHR P16473 2/20 0.33
LMNA P02545 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26893427 1.00 LGALS1 (0.41) LGALS1LGALS3LGALS9LGALS8PYGB
SCHEMBL26698792 1.00 LGALS1 (0.41) LGALS1LGALS3LGALS9LGALS8PYGB
SCHEMBL25867409 0.80 LGALS1 (0.38) LGALS1LGALS3LGALS9LGALS8PYGB
SCHEMBL5444302 0.71 LGALS1 (0.59) LGALS1LGALS3LGALS9LGALS8PYGB
SCHEMBL5444372 0.71 LGALS1 (0.59) LGALS1LGALS3LGALS9LGALS8PYGB
SCHEMBL5446587 0.71 LGALS1 (0.59) LGALS1LGALS3LGALS9LGALS8PYGB
SCHEMBL15370355 0.71 LGALS1 (0.59) LGALS1LGALS3LGALS9LGALS8PYGB
SCHEMBL24115372 0.71 LGALS1 (0.59) LGALS1LGALS3LGALS9LGALS8PYGB
SCHEMBL18383814 0.71 LGALS1 (0.59) LGALS1LGALS3LGALS9LGALS8PYGB
SCHEMBL24243426 0.71 LGALS1 (0.59) LGALS1LGALS3LGALS9LGALS8PYGB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4097138-A1 ASGPR-BINDING COMPOUNDS FOR THE DEGRADATION OF EXTRACELLULAR PROTEINS Avila Therapeutics, Inc. (US) 2022-12-07 EP disclosed
WO-2021155317-A1 ASGPR-BINDING COMPOUNDS FOR THE DEGRADATION OF EXTRACELLULAR PROTEINS AVILAR THERAPEUTICS, INC. (US) 2021-08-05 WO disclosed